Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Anthony

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
JCI Insight|July 27, 2018
SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipationPeter M Haggie, Onur Cil, Sujin Lee, et al.
Nutrition & Metabolism|July 17, 2020
Genetic determinants of obesity heterogeneity in type II diabetesSomayeh Alsadat Hosseini Khorami, Mohd Sokhini Abd Mutalib, Mohammad Feili Shiraz, et al.
European Journal of Medicinal Chemistry|December 6, 2024
High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diureticsRiya J Master, Joy Karmakar, Peter M Haggie, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 14, 2018
ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 ReporterPuay-Wah Phuan, Guido Veit, Joseph-Anthony Tan, et al.
RSC Medicinal Chemistry|November 17, 2023
Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disordersTifany Chu, Joy Karmakar, Peter M Haggie, et al.
Pacing and Clinical Electrophysiology : PACE|October 28, 2008
Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of lifeManish Undavia, Nathan E Goldstein, Pilar Cohen, et al.
Physical Therapy|December 19, 2015
Raising the Priority of Lifestyle-Related Noncommunicable Diseases in Physical Therapy CurriculaElizabeth Dean, Alison Greig, Sue Murphy, et al.
Scientific Reports|November 29, 2019
Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutantsPuay-Wah Phuan, Joseph-Anthony Tan, Amber A Rivera, et al.
Nutrients|August 10, 2021
Correlation between Levels of Vitamins D<sub>3</sub> and E in Type 2 Diabetes Mellitus: A Case-Control Study in Serdang, Selangor, MalaysiaNurliyana Najwa Md Razip, Banulata Gopalsamy, Mohd Sokhini Abdul Mutalib, et al.
Journal of Neurointerventional Surgery|May 18, 2022
Intra-arterial chemotherapy for retinoblastomaJoseph Anthony Carnevale, Jacob Goldberg, Gary Kocharian, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
JCI Insight|July 27, 2018
SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipationPeter M Haggie, Onur Cil, Sujin Lee, et al.
Nutrition & Metabolism|July 17, 2020
Genetic determinants of obesity heterogeneity in type II diabetesSomayeh Alsadat Hosseini Khorami, Mohd Sokhini Abd Mutalib, Mohammad Feili Shiraz, et al.
European Journal of Medicinal Chemistry|December 6, 2024
High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diureticsRiya J Master, Joy Karmakar, Peter M Haggie, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 14, 2018
ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 ReporterPuay-Wah Phuan, Guido Veit, Joseph-Anthony Tan, et al.
RSC Medicinal Chemistry|November 17, 2023
Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disordersTifany Chu, Joy Karmakar, Peter M Haggie, et al.
Pacing and Clinical Electrophysiology : PACE|October 28, 2008
Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of lifeManish Undavia, Nathan E Goldstein, Pilar Cohen, et al.
Physical Therapy|December 19, 2015
Raising the Priority of Lifestyle-Related Noncommunicable Diseases in Physical Therapy CurriculaElizabeth Dean, Alison Greig, Sue Murphy, et al.
Scientific Reports|November 29, 2019
Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutantsPuay-Wah Phuan, Joseph-Anthony Tan, Amber A Rivera, et al.
Nutrients|August 10, 2021
Correlation between Levels of Vitamins D<sub>3</sub> and E in Type 2 Diabetes Mellitus: A Case-Control Study in Serdang, Selangor, MalaysiaNurliyana Najwa Md Razip, Banulata Gopalsamy, Mohd Sokhini Abdul Mutalib, et al.
Journal of Neurointerventional Surgery|May 18, 2022
Intra-arterial chemotherapy for retinoblastomaJoseph Anthony Carnevale, Jacob Goldberg, Gary Kocharian, et al.
Pageof 11